1. Home
  2. BIRK vs HAE Comparison

BIRK vs HAE Comparison

Compare BIRK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birkenstock Holding plc

BIRK

Birkenstock Holding plc

SELL

Current Price

$34.32

Market Cap

5.5B

Sector

N/A

ML Signal

SELL

HAE

Haemonetics Corporation

HOLD

Current Price

$119.20

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIRK
HAE
Founded
1774
1971
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.8B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
BIRK
HAE
Price
$34.32
$119.20
Analyst Decision
Buy
Buy
Analyst Count
23
11
Target Price
$50.32
★ $124.50
AVG Volume (30 Days)
★ 1.7M
620.2K
Earning Date
08-13-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.72
Revenue
N/A
★ $910,373,000.00
Revenue This Year
$11.98
$6.21
Revenue Next Year
$13.81
$5.54
P/E Ratio
★ $17.48
$168.90
Revenue Growth
★ N/A
N/A
52 Week Low
$29.93
$48.98
52 Week High
$50.73
$123.77

Technical Indicators

Market Signals
Indicator
BIRK
HAE
Relative Strength Index (RSI) 52.80 68.85
Support Level $33.06 $100.92
Resistance Level $37.29 N/A
Average True Range (ATR) 1.07 3.35
MACD 0.34 1.12
Stochastic Oscillator 45.21 79.65

Price Performance

Historical Comparison
BIRK
HAE

About BIRK Birkenstock Holding plc

Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Share on Social Networks: